A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy
Journal of Allergy and Clinical Immunology · 2024
DOI: 10.1016/j.jaci.2024.04.022 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024. Verfasst von Edward Zoratti und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Medicine, Henry Ford Health, Detroit, Mich. Electronic address: ezoratt1@hfhs.org. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Allergens, Asthma, Immunoglobulin E. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, U.S. Department of Health and Human Services, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: Cockroach allergy contributes to morbidity among urban children with asthma. Few trials address the effect of subcutaneous immunotherapy (SCIT) with cockroach allergen among these at-risk children. OBJECTIVES: We sought to determine whether nasal allergen challenge (NAC) responses to cockroach allergen would improve following 1 year of SCIT. METHODS: Urban children with asthma, who were cockroach-sensitized and reactive on NAC, participated in a year-long randomized double-blind placebo-controlled SCIT trial using German cockroach extract. The primary endpoint was the change in mean Total Nasal Symptom Score (TNSS) during NAC after 12 months of SCIT. Changes in nasal transcriptomic responses during NAC, skin prick test wheal size, serum allergen-specific antibody production, and T-cell responses to cockroach allergen were assessed. RESULTS: Changes in mean NAC TNSS did not differ between SCIT-assigned (n = 28) versus placebo-assigned (n = 29) participants (P = .63). Nasal transcriptomic responses correlated with TNSS, but a treatment effect was not observed. Cockroach serum-specific IgE decreased to a similar extent in both groups, while decreased cockroach skin prick test wheal size was greater among SCIT participants (P = .04). A 200-fold increase in cockroach serum-specific IgG4 was observed among subjects receiving SCIT (P < .001) but was unchanged in the placebo group. T-cell IL-4 responses following cockroach allergen stimulation decreased to a greater extent among SCIT versus placebo (P = .002), while no effect was observed for IL-10 or IFN-γ. CONCLUSIONS: A year of SCIT failed to alter NAC TNSS and nasal transcriptome responses to cockroach allergen challenge despite systemic effects on allergen-specific skin tests, induction of serum-specific IgG4 serum production and down-modulation of allergen-stimulated T-cell responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Department of Medicine, Henry Ford Health, Detroit, Mich. Electronic address: ezoratt1@hfhs.org.
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md.
- InBio, Inc, Charlottesville, Va.
- La Jolla Institute for Immunology, La Jolla, Calif.
- Department of Medicine, University of Washington, Seattle, Wash.
- Benaroya Research Institute, Seattle, Wash.
Förderung
- NIAID NIH HHS
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Zoratti, E., Wood, R., Pomés, A., Da Silva Antunes, R., Altman, M. C., Benson, B., Wheatley, L. M., Cho, K., Calatroni, A., Little, F. F., Pongracic, J., Makhija, M., Khurana Hershey, G. K., Sherenian, M. G., Rivera-Spoljaric, K., Stokes, J. R., Gill, M. A., Gruchalla, R. S., Chambliss, J., …, & Inner-City Asthma and Childhood Asthma in Urban Settings Consortia (2024). A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.04.022
Vancouver
Zoratti E, Wood R, Pomés A, Da Silva Antunes R, Altman MC, Benson B, et al. A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy. Journal of Allergy and Clinical Immunology. 2024. doi:10.1016/j.jaci.2024.04.022
BibTeX
@article{Zoratti2024,
author = {Zoratti, Edward and Wood, Robert and Pomés, Anna and Da Silva Antunes, Ricardo and Altman, Matthew C and Benson, Basilin and Wheatley, Lisa M and Cho, Kate and Calatroni, Agustin and Little, Frederic F and Pongracic, J and Makhija, Melanie and Khurana Hershey, Gurjit K and Sherenian, Michael G and Rivera-Spoljaric, Katherine and Stokes, Jeffrey R and Gill, Michelle A and Gruchalla, Rebecca S and Chambliss, Jeffrey and Liu, Andrew H and Kattan, Meyer and Busse, Paula J and Bacharier, Leonard B and Sheehan, William and Kim, Haejin and Glesner, Jill and Gergen, Peter J and Togias, Alkis and Baucom, Jessica L and Visness, Cynthia M and Sette, Alessandro and Busse, William W and Jackson, Daniel J and Inner-City Asthma and Childhood Asthma in Urban Settings Consortia, Inner-City Asthma and Childhood Asthma in Urban Settings Consortia},
title = {A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy},
journal = {Journal of Allergy and Clinical Immunology},
year = {2024},
doi = {10.1016/j.jaci.2024.04.022}
}
EUVIMED